- Home
- ACEL vs NTLA Comparison
ACEL vs NTLA Comparison
Compare ACEL & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- NTLA
- Stock Information
- Founded
- ACEL 2009
- NTLA 2014
- Country
- ACEL United States
- NTLA United States
- Employees
- ACEL N/A
- NTLA N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- ACEL Consumer Discretionary
- NTLA Health Care
- Exchange
- ACEL Nasdaq
- NTLA Nasdaq
- Market Cap
- ACEL 925.5M
- NTLA 959.4M
- IPO Year
- ACEL N/A
- NTLA 2016
- Fundamental
- Price
- ACEL $10.72
- NTLA $9.50
- Analyst Decision
- ACEL Strong Buy
- NTLA Buy
- Analyst Count
- ACEL 1
- NTLA 17
- Target Price
- ACEL $16.00
- NTLA $53.00
- AVG Volume (30 Days)
- ACEL 205.3K
- NTLA 3.0M
- Earning Date
- ACEL 02-26-2025
- NTLA 02-20-2025
- Dividend Yield
- ACEL N/A
- NTLA N/A
- EPS Growth
- ACEL 4.41
- NTLA N/A
- EPS
- ACEL 0.51
- NTLA N/A
- Revenue
- ACEL $1,210,525,000.00
- NTLA $43,086,000.00
- Revenue This Year
- ACEL $6.12
- NTLA $52.50
- Revenue Next Year
- ACEL $2.74
- NTLA $0.42
- P/E Ratio
- ACEL $21.00
- NTLA N/A
- Revenue Growth
- ACEL 5.13
- NTLA N/A
- 52 Week Low
- ACEL $9.37
- NTLA $9.25
- 52 Week High
- ACEL $12.96
- NTLA $34.87
- Technical
- Relative Strength Index (RSI)
- ACEL 46.67
- NTLA 27.36
- Support Level
- ACEL $10.08
- NTLA $9.25
- Resistance Level
- ACEL $10.78
- NTLA $10.39
- Average True Range (ATR)
- ACEL 0.22
- NTLA 0.68
- MACD
- ACEL 0.05
- NTLA -0.16
- Stochastic Oscillator
- ACEL 76.51
- NTLA 6.11
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming operator in the United States. It is engaged in the installation, maintenance, and operation of video gaming terminals. The company offers products to restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. It operates slot machines and amusement equipment. The company generates a majority of its revenue from net gaming. Net gaming revenue represents net cash received from gaming activities, which is the difference between gaming wins and losses. Net gaming revenue includes the amount earned by location partners and is recognized at the time of gaming play.
About NTLA Intellia Therapeutics Inc.
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.